EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Tadalafil 5 mg Once Daily Improves Lower Urinary Tract Symptoms and Erectile Dysfunction: A Systematic Review and Meta‐analysis

Yilin WANG, Yiping BAO, Jie LIU, Lijun DUAN, Yuanshan CUI

LUTS: Lower Urinary Tract Symptoms · 2018-01 · 10 (1) · 84-92

DOI: 10.1111/luts.12144 ↗
AbstractBibliografische Angaben

Abstract

Objectives We carried out a systematic review and meta‐analysis to assess tadalafil 5 mg once‐daily for the treatment of lower urinary tract symptoms ( LUTS ) and erectile dysfunction ( ED ). Methods A literature review was performed to identify all published randomized double‐blind, placebo‐controlled trials of tadalafil 5 mg once‐daily for the treatment of LUTS and ED . The search included the following databases: MEDLINE , EMBASE , and the Cochrane Controlled Trials Register. The reference lists of the retrieved studies were also investigated. Results Thirteen publications involving a total of 3973 patients were used in the analysis, including 13 RCTs that compared tadalafil 5 mg once‐daily with placebo. We found that tadalafil 5 mg once‐daily was effective in improving LUTS suggestive of BPH and treating ED over 12 weeks in our meta‐analysis. Total International Prostate Symptom Score ( IPSS ) ( SMD = − 2.02, 95% CI = − 2.52 to −1.53, P < 0.00001); Benign Prostatic Hyperplasia Impact Index ( BPH‐II ) ( SMD = −0.58, 95% CI = −0.84 to −0.33, P < 0.00001); International Index of Erectile Function‐erectile function ( IIEF ) domain (standardized mean difference [ SMD ] = 5.18, 95% confidence interval [ CI ] = 4.13–6.23, P < 0.00001) indicated that tadalafil 5 mg once‐daily was more effective than the placebo. Safety assessments included discontinuations due to adverse event (odds ratio ( OR ) = 1.79, 95% CI = 1.12–2.85, P = 0.01) indicated that tadalafil 5 mg once‐daily was well tolerated. Conclusions This meta‐analysis indicates that tadalafil 5 mg once‐daily to be an effective treatment for LUTS and ED with a low occurrence of side effects.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →